Open AccessLong‐lasting Effect Against White Spot Syndrome Virus in Shrimp Broodstock, Litopenaeus vannamei , by LvRab7 Silencing
Author(s) -
AlvarezRuiz Píndaro,
LunaGonzález Antonio,
EscamillaMontes Ruth,
MejíaRuiz Claudio H.,
MagallónBarajas Francisco J.,
LleraHerrera Raúl,
GalvánAlvarez Diego A.
Publication year - 2015
Publication title -
journal of the world aquaculture society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 60
eISSN - 1749-7345
pISSN - 0893-8849
DOI - 10.1111/jwas.12236
Subject(s) - white spot syndrome , biology , broodstock , shrimp , rna interference , rna silencing , gene silencing , litopenaeus , virology , virus , gene , fishery , genetics , rna , aquaculture , fish <actinopterygii>
The white spot syndrome virus ( WSSV ) remains the most devastating viral pathogen of shrimp culture worldwide. Gene silencing by RNA interference ( RNAi ) using double stranded RNA ( dsRNA ) has been considered a powerful tool for conferring protection against WSSV when viral genes are silenced, as documented in several shrimp species. However, this effect is not long lasting. Our results provide the first evidence that long‐term silencing of the LvRab7 endogen produced antiviral effect against WSSV , which endured at least 21 d after dsRNA treatment (dat). Until now, the most efficient way to implement RNAi with dsRNA into the shrimp is by injection. Consequently, its application to broodstock in hatcheries is possible, minimizing the risk of vertical transmission of the virus. We show that the expression of Rab7 in hemocytes is lowest at 2 dat and finally recovers to basal status. In contrast, in gills and pleopods, gene expression silencing continued for at least 21 d. We challenged Litopenaeus vannamei broodstock with WSSV at 7, 14, or 21 dat reaching mortality rates of 0, 40, and 27%, respectively. In conclusion, the LvRab7 gene silencing is progressive and effective against WSSV . However, further studies are necessary to elucidate the functions of Rab7 in shrimp cells before applying this methodology at a commercial level.